
Publication
Scams in superannuation: Integrating operational and strategic resilience
Scammers are increasingly using advanced tools to target superannuation assets, endangering members' retirement savings.
Global | Publication | March 2016
The fourth edition of the Life Sciences Law Review provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in 30 jurisdictions. As before, each chapter contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business. Each of the chapters has been prepared by a recognised expert in the relevant jurisdiction, and the resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.
Publication
Scammers are increasingly using advanced tools to target superannuation assets, endangering members' retirement savings.
Publication
Since the early 20th century, Australian courts have emphasised the obligation for the Commonwealth to act as a ‘model litigant’ in court proceedings.
Publication
The destruction of the 46,000-year-old Juukan Gorge rock shelters in 2020 was a wakeup call for project proponents on the importance of successfully managing Aboriginal and Torres Strait Islander cultural heritage risks.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025